Hi Raymond,

Per the 3rd party Cancer Drug Valuation(s) Full Report linked from this website:

On November 8, 2023; Capizate, Inc. (a 3rd party entity) reported a "Situation Analysis of GBXi" that it performed at GBXI's request; based upon 25 documents provided by GBXI; mostly pertaining to Cannabis Science, Inc. This report included listing: (a) Strengths, (b) Areas for Improvement, (c) CBIS Cancer Drug Valuation(s) [1 specifically], (d) as well as several additional items that supported it giving GBXI a Capitize Score = 623 out of a possible 1000. Getting the potential CBIS Drug Valuation(s) for just 1 drug @ 25Mil-29Mil is/was impressive; however the "Areas for Improvement" are significant:

Areas for improvement
---------------------
1. The business documents, agreements, term sheets, engagements are all dated in 2017-2018 and need to be updated.
2. Ownership and control of the intellectual property needs to be defined and confirmed.
3. A similar entity has active registration with California Secretary of State. The Company has a different address than on the Company website and also had a Statement of Info due to the California Secretary of State on 05/10/2023. Registered with the California Secretary of State as a Non-Profit Nonprofit Corporation - CA - Mutual Benefit. This will need to be defined.

Can you please let us know about the progress that has been made toward resolving these issues?? Even if you could reveal an estimated % complete for each line item that would be nice to see.

The report from November 8, 2023 says:  "Your current phase in our process is phase three (Situation Analysis), four (Due Diligence Score), and five (Business Finance Documents – Specifically the analysis) the potential valuation" - out of a 7 phase process; (6) Capital Markets and (7) Post Capitalization. Even if you choose not to continue to use Capitize, Inc. any longer; these "Areas of Improvement" listed MUST BE addressed in order to bring CBIS back Trading again.

Thank you in advance of your response and Best Regards,

...Francis G. Cormier III

Hi Raymond,

Per the 3rd party Cancer Drug Valuation(s) Full Report linked from this website:

On November 8, 2023; Capizate, Inc. (a 3rd party entity)... Show more

Raymond C. Dabney, KELLY PINGSTERHAUS and 4 others

Raymond C. Dabney Everything has it's Priority. Not being sick anymore was Priority Number 1.

Now that I'm past that NASTY Sickness phase we can resume the FIREWORKS... Show more 11 months ago

•••

Francis Cormier Thank you Raymond for your response. Glad to hear that you are on the mend. Best Regards, Francis - looking forward to future updates. 11 months ago

•••

Raymond C. Dabney You're welcome and Thank you Francis! It's been a Battle, that's for sure! Playing catch up with everyone responding to the Legacy Drug Ownership... Show more 11 months ago

•••

Raymond C. Dabney Thanks for reading our updates Guys! That is correct we are ALL waiting patiently for the same stock exchange approval process.

Not sure how many... Show more 11 months ago

•••

Alvin Kline Who would be nice to see some trading going on won't be long I'm going to be in granite City I hope it don't take that long 9 months ago

•••

Alvin Kline Well for waiting for the government to get anything done we're in big trouble because they don't even know who the hell the president is yet 9 months ago

•••

American States University

*** Warning this document contains graphic images.

Click the Below Image to Review our Cancer Drug Comparables

1st HARVARD Award Winning
Stage 4 Lung Cancer Killing Article:

*** Please click image below.

2nd HARVARD Award Winning
Stage 4 Lung Cancer Killing Article:

*** Please click image below.

*** PLUS

(3) other Cannabis Science
REAL WORLD Successes:

Stage 4 Breast Cancer

Skin Cancer

Karposis Sarcoma

The ASU Digital Business HUB will be used as the main business student learning center. GBXI will be the main pivot point to spin out trading shares of all our Partner Public and Private Companies such as Cannabis Science, iCannabinoid, Thermic Science, LNC, LMG, and a few more old and new school surprises for our loyal shareholders. No one will be missed! A true Digital Business HUB for students, just as planned all along.

Each spinout company will give our GBXI registered shareholders additional pro-rata shares in each spinout company over and above their original shares in each entity. This provides the required shareholder base for each company required to trade and gives additional shares to all our loyal GBXI shareholders.

We call this “Compounding our Wealth” through extra spinout share participation for all our loyal GBXI shareholders. Each registered GBXI shareholder will receive additional shares of each spinout Company over and above their original shares to enjoy additional liquidity as each company begins to trade through the GBXI Digital Business HUB spinout process.

Click here to review the Report:

Case No. 2:17-CV-02271-KJM-JDP

Inspire, Dream, Change

YOUR DIGITAL ERA Personal & Business Access Learning HUB

Photos

Observational Studies

CSi-VIP & CBIS-Shareholder Legacy

Click the ABOVE Image to Review our 1-Million Strong FC, Media Kit

*** Warning this document contains exciting images.

Please Click the above image for information to become a CSi-VIP & CSi-VIP Legacy Cancer Drug Owner

Pease Click the Calendar image to book your time to speak with Mr. Dabney about "Your Final CSi-VIP Shareholder Legacy".

Click the above Image to become one of the First 1-Million Strong Killing Cancers, Fight Club Members to help 'Make that Change' Join in Now! * Warning this Membership contains Exciting Results.

PS ...** ALL of our CSi-VIP's and those who Donated through the ASU/CSi-EDP GO-Fund-Me Promotion you do not need to purchase anything, you are ALREADY included in the "First" 1-Million Membership Club, CONGRATULATIONS !!!

Cannabis Science CEO, Presents …

The FINAL “CBIS GIFT Shares” Issuances!

DECEMBER 2024, Cheers! & HAPPY HOLIDAYS !!!

ALL GIFT Shares 1, 2, & 3 being ISSUED !!!

LAST Steps:

Please confirm Yours NOW !!!

1. CONFIRM Correct Total Share Amount(s)

2. CONFIRM Correct Name(s) on CERTIFICATE

3. CONFIRM Correct Mailing Address

*** giftshares@icannabinoid.com

ASU/CSi-EDP-ECO-System
At it's FINEST !!!

WHICH ONE ARE YOU ??

Those who, MAKE things happen.
Those who WATCH things happen.
Those who WONDER what the ... HAPPENED ???

We can make this HAPPEN way FASTER Working as a TEAM !!!

WHAT Matters is how much you CARE about KILLING CANCERS ...

This is it ... We are ALL Here ... Now ... with a Bunch of Celebrities going on TV Worldwide to Start raising $20 Million to Keep Killing Cancers.

2025 Audit considerations NASDAQ.

Cannabis Science Inc.
Share Structure 2025

Par Value: $0.001 USD
Last Price: $0.00647 USD
OTC Markets.

Common Stock:
Authorized:
5,000,000,000

Issued:
2,839,095,296

Fully Diluted:
4,510,547,648

Class A Common Stock
Authorized:
100,000,000

Issued:
0

Class B Common Stock
Authorized:
1,500,000,000

Issued:
0

Preferred Stock
Authorized:
1,000,000

Issued:
1,000,000

Sign up for a FREE Assessment to JOIN the UNIVERSITY Team or any ASU/CSi-EDP Team for whatever your AREA of Expertise is … then say no more… you already know.

You already know our Extensive LIST of GROUNDBREAKING Products.

1-Million STRONG TV Coverage, HARVARD Award Success.

TAKE YOUR PICK AND BECOME A PART OF HISTORICAL CHANGE

*** APPLY for FREE in CONFIDENCE and Success.

Each Product launch WE RELEASE will include Equity Participation according to standard salaries and share bonus structures.

EVERYONE sign up to add your STRENGTHS to OUR COMBINED SUCCESS and lets MAKE THIS HAPPEN NOW !!!

Activity Stream